Repositório Covid-19

While recent literature has shown the efficacy of the SARS-CoV-2 vaccine in preventing infection, it’s impact on need for emergency...

There are limited data on the effectiveness of the vaccines against symptomatic coronavirus disease 2019 (Covid-19) currently authorized in the...

The lack of effective treatment options to reduce COVID-19 associated mortality, disease progression, and the need for invasive mechanical ventilation...

Corona Virus Disease 2019 (COVID-19), referred to as ‘New Coronary Pneumonia’, is a type of acute infectious disease caused by...

Antibodies are made by the body as a defence against disease. However, they can also be produced in a laboratory...

The coronavirus disease 2019 has infected over 150 million people worldwide and led to over 3 million deaths. Severe acute...

The novel coronavirus SARS-CoV-2 since its emergence at Wuhan, China in December 2019 has been creating global health turmoil despite...

The aim of the study is to study the utility of various inflammatory markers in predicting outcomes of hospitalized patients...

Severe coronavirus disease-2019 (COVID-19) can progress to an acute respiratory distress syndrome (ARDS), which involves alveolar infiltration by activated neutrophils....

The growing use of short-interfering RNA (siRNA)-based therapeutics for viral diseases reflects the most recent innovations in anti-viral vaccines and...

The SARS-CoV-2 main protease (Mpro) is one of the molecular targets for drug design. Effective vaccines have been identified as...

The causative factor of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuously mutating. Interestingly, identified mutations mainly occur...